These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 14678718)

  • 1. Changing paradigms in dermatology: topical immunomodulators within a permutational paradigm for the treatment of atopic and eczematous dermatitis.
    Abramovits W; Goldstein AM; Stevenson LC
    Clin Dermatol; 2003; 21(5):383-91. PubMed ID: 14678718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Topical immunomodulators for treatment of eczema].
    Heine G; Sterry W; Worm M
    Wien Med Wochenschr; 2003; 153(23-24):522-5. PubMed ID: 14733065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The economics of topical immunomodulators for the treatment of atopic dermatitis.
    Abramovits W; Boguniewicz M; Paller AS; Whitaker-Worth DL; Prendergast MM; Tokar M; Tong KB
    Pharmacoeconomics; 2005; 23(6):543-66. PubMed ID: 15960552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical tacrolimus for atopic dermatitis.
    Cury Martins J; Martins C; Aoki V; Gois AF; Ishii HA; da Silva EM
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009864. PubMed ID: 26132597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spotlight on topical pimecrolimus in atopic dermatitis.
    Wellington K; Jarvis B
    Am J Clin Dermatol; 2002; 3(6):435-8. PubMed ID: 12113651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical pimecrolimus: a review of its clinical potential in the management of atopic dermatitis.
    Wellington K; Jarvis B
    Drugs; 2002; 62(5):817-40. PubMed ID: 11929333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Topical immunomodulators, such as tacrolimus and pimecrolimus, in the treatment of atopic dermatitis].
    de Bruin-Weller MS; Bruijnzeel-Koomen CA
    Ned Tijdschr Geneeskd; 2005 May; 149(20):1096-100. PubMed ID: 15932135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [How I treat ... atopic dermatitis by topical pimecrolimus (Elidel). The emerging paradigm of calcineurin inhibitors].
    Piérard-Franchimont C; Quatresooz P; Piérard GE
    Rev Med Liege; 2005 Mar; 60(3):136-40. PubMed ID: 15884695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of pimecrolimus cream 1% on different morphological signs of eczema in infants with atopic dermatitis.
    Breuer K; Braeutigam M; Kapp A; Werfel T
    Dermatology; 2004; 209(4):314-20. PubMed ID: 15539895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spotlight on topical pimecrolimus in pediatric atopic dermatitis.
    Yang LP; Curran MP
    Am J Clin Dermatol; 2010; 11(4):295-8. PubMed ID: 20509720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pimecrolimus 1% cream (Elidel) for atopic dermatitis.
    Bernard LA; Bergman JN; Eichenfield LF
    Skin Therapy Lett; 2002 Apr; 7(4):1-3. PubMed ID: 12097994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of tacrolimus ointment versus pimecrolimus cream in the treatment of patients with atopic dermatitis previously treated with corticosteroids.
    Kirsner RS; Heffernan MP; Antaya R
    Acta Derm Venereol; 2010; 90(1):58-64. PubMed ID: 20107727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
    Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K
    J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis.
    Hultsch T; Kapp A; Spergel J
    Dermatology; 2005; 211(2):174-87. PubMed ID: 16088174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New treatments of atopic dermatitis].
    Taïeb A; Boralevi F
    Arch Pediatr; 2005 Apr; 12(4):491-7. PubMed ID: 15808446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two topical calcineurin inhibitors for the treatment of atopic dermatitis in pediatric patients: a meta-analysis of randomized clinical trials.
    Chen SL; Yan J; Wang FS
    J Dermatolog Treat; 2010 May; 21(3):144-56. PubMed ID: 20394490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The treatment of atopic dermatitis in adults with topical calcineurin inhibitors].
    Meurer M; Wozel G
    Hautarzt; 2003 May; 54(5):424-31. PubMed ID: 12719862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse.
    Cork MJ; Britton J; Butler L; Young S; Murphy R; Keohane SG
    Br J Dermatol; 2003 Sep; 149(3):582-9. PubMed ID: 14510993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Topical immunomodulators?": introducing old friends and a new ally, tacrolimus.
    Nghiem P
    J Am Acad Dermatol; 2001 Jan; 44(1):111-3. PubMed ID: 11148486
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of nonsteroidal topical immunomodulators for the treatment of atopic dermatitis in the pediatric population.
    Paller AS
    J Pediatr; 2001 Feb; 138(2):163-8. PubMed ID: 11174611
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.